Lixumistat

SI-7900

Lixumistat, >98% (HPLC)

CAS No. : [1422365-93-2]

Synonyms : IM-156 free base; HL-156A free base; HL-271 free base

IUPAC Name : N-(N-(4-(Trifluoromethoxy)phenyl)carbamimidoyl)pyrrolidine-1-carboximidamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Lixumistat potently activates AMPK and inhibits OXPHOS while avoiding the classic metabolic liabilities of metformin, such as hypoglycemia and weight loss. Its pharmacological profile supports notable efficacy in models of age‑related cognitive impairment and pulmonary fibrosis.

References : Bang E. et al.: Exp. Neurobiol., 27(1), 45-56, 2018; Willette R. N. et al.: J. Pharmacol Exp.Ther., 379(3), 290-300, 2021; Row H. et al.: Biochem. Biophys. Res. Commun., 469(3), 783-789, 2016.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.